drugset / Trial / NCT07852962
Study to Assess Drug Levels, Immune Response, Safety and Tolerability of BMS-986446 in Healthy Chinese Participants.
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to assess the drug levels, immune response, safety and tolerability of BMS-986446 in healthy Chinese participants.
Timeline
- Start
- 2027-02-10
- Primary completion
- 2027-07-18
- Completion
- 2027-07-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-986446 | Monoclonal antibody | — | Intravenous |
Indications
No indication recorded.